1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 3: 
Comparison in incidental findings between subjects with 22q11DS and typically developing (PNC) sample
22q11DSPNCP Value
Pineal cyst2.58%2.43%.6213
Other cyst0%1.36%.9855
Cavum septum pellucidum18.96%1.14%<.0001
Vascular abnormalities8.62%2.57%.0173
White matter11.53%0.56%<.0001
Subcortical3.45%0.06%.0960
Cerebellar0%2.36%.9860
All incidental46.55%10.72%a<.0001
  • Note:—VCFS indicates velocardiofacial syndrome.
  • ↵a Previously reported as 10.57%, with WM and subcortical abnormalities included in the current analyses.